We are a global vertically integrated pharmaceutical company engaged in research and development, manufacture, sale and distribution of prescription and OTC pharmaceutical products, with global presence in more than 50 countries, including United States, Europe, Canada, Japan, Australia and Rest of the World. We offer a wide range of proprietary finished dosage formulation catering to different therapeutic segments, including CVS, CNS, gastro-intestinal, etc. in multiple dosage forms including:
Jubilant Generics is a subsidiary of Jubilant Pharma.
Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to our customers across geographies. We organise our pharma business into three segments. Firstly, ‘Specialty Pharmaceuticals’ comprising Radiopharmaceuticals (including Radiopharmacies) and Allergy Therapy Products. Secondly, our ‘CDMO’ segment, comprising Parenteral Contract Manufacturing and Active Pharmaceutical Ingredients. Finally, the ‘Generics’ segment is for our Finished Dosage Formulations business.
We supply our products and services to customers in over 85 countries. We have four manufacturing facilities in North America and two in India, coupled with research and development centers in North America and India. Additionally, we have a distribution network of more than 50 radiopharmacies in the United States.